• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清镁水平对晚期慢性肾病患者全因死亡率和心血管结局无影响。

Lack of influence of serum magnesium levels on overall mortality and cardiovascular outcomes in patients with advanced chronic kidney disease.

作者信息

Ortega Olimpia, Rodriguez Isabel, Cobo Gabriela, Hinostroza Julie, Gallar Paloma, Mon Carmen, Ortiz Milagros, Herrero Juan Carlos, Di Gioia Cristina, Oliet Aniana, Vigil Ana

机构信息

Nephrology Service, Hospital Severo Ochoa, Avenida Orellana s/n, Leganés 28911, Madrid, Spain.

出版信息

ISRN Nephrol. 2013 Jun 19;2013:191786. doi: 10.5402/2013/191786. eCollection 2013.

DOI:10.5402/2013/191786
PMID:24959538
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4045427/
Abstract

Background. Low serum magnesium has been associated with an increased cardiovascular risk in the general population and in dialysis patients. Our aim was to analyze the influence of serum magnesium on overall mortality and cardiovascular outcomes in patients with advanced CKD not yet on dialysis. Methods. Seventy patients with CKD stages 4 and 5 were included. After a single measurement of s-magnesium, patients were followed a mean of 11 months. Primary end-point was death of any cause, and secondary end-point was the occurrence of fatal or nonfatal CV events. Results. Basal s-magnesium was within normal range (2.1 ± 0.3 mg/dL), was lower in men (P = 0.008) and in diabetic patients (P = 0.02), and was not different (P = 0.2) between patients with and without cardiopathy. Magnesium did not correlate with PTH, calcium, phosphate, albumin, inflammatory parameters (CRP), and cardiac (NT-proBNP) biomarkers but correlated inversely (r = -0.23; P = 0.052) with the daily dose of loop diuretics. In univariate and multivariate Cox proportional hazard models, magnesium was not an independent predictor for overall mortality or CV events. Conclusions. Our results do not support that serum magnesium can be an independent predictor for overall mortality or future cardiovascular events among patients with advanced CKD not yet on dialysis.

摘要

背景。低血清镁与普通人群及透析患者心血管风险增加相关。我们的目的是分析血清镁对尚未接受透析的晚期慢性肾脏病(CKD)患者全因死亡率和心血管结局的影响。方法。纳入70例CKD 4期和5期患者。单次测量血清镁后,对患者平均随访11个月。主要终点是任何原因导致的死亡,次要终点是致命或非致命心血管事件的发生。结果。基础血清镁在正常范围内(2.1±0.3mg/dL),男性(P = 0.008)和糖尿病患者(P = 0.02)的血清镁较低,有心脏病和无心脏病患者之间无差异(P = 0.2)。镁与甲状旁腺激素、钙、磷、白蛋白、炎症参数(CRP)及心脏(NT-proBNP)生物标志物均无相关性,但与襻利尿剂的每日剂量呈负相关(r = -0.23;P = 0.052)。在单因素和多因素Cox比例风险模型中,镁不是全因死亡率或心血管事件的独立预测因素。结论。我们的结果不支持血清镁可作为尚未接受透析的晚期CKD患者全因死亡率或未来心血管事件的独立预测因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e90f/4045427/fecc738945ba/ISRN.NEPHROLOGY2013-191786.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e90f/4045427/7affce01f266/ISRN.NEPHROLOGY2013-191786.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e90f/4045427/fecc738945ba/ISRN.NEPHROLOGY2013-191786.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e90f/4045427/7affce01f266/ISRN.NEPHROLOGY2013-191786.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e90f/4045427/fecc738945ba/ISRN.NEPHROLOGY2013-191786.002.jpg

相似文献

1
Lack of influence of serum magnesium levels on overall mortality and cardiovascular outcomes in patients with advanced chronic kidney disease.血清镁水平对晚期慢性肾病患者全因死亡率和心血管结局无影响。
ISRN Nephrol. 2013 Jun 19;2013:191786. doi: 10.5402/2013/191786. eCollection 2013.
2
[Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].3、4、5期慢性肾脏病(未透析)患者矿物质代谢的变化
Nefrologia. 2008;28 Suppl 3:67-78.
3
Hypomagnesemia Is Associated with Increased Mortality among Peritoneal Dialysis Patients.低镁血症与腹膜透析患者死亡率增加有关。
PLoS One. 2016 Mar 29;11(3):e0152488. doi: 10.1371/journal.pone.0152488. eCollection 2016.
4
Relationship between serum magnesium levels and cardiovascular events in chronic kidney disease patients.血清镁水平与慢性肾脏病患者心血管事件的关系。
Am J Nephrol. 2012;36(3):228-37. doi: 10.1159/000341868. Epub 2012 Aug 30.
5
Baseline Serum Magnesium Level and Its Variability in Maintenance Hemodialysis Patients: Associations with Mortality.维持性血液透析患者的基线血清镁水平及其变异性与死亡率的关系。
Kidney Blood Press Res. 2019;44(2):222-232. doi: 10.1159/000498957. Epub 2019 Mar 28.
6
Nontraditional cardiovascular biomarkers and estimation of cardiovascular risk in predialysis chronic kidney disease patients and their correlations with carotid intima media thickness.非传统心血管生物标志物与透析前慢性肾脏病患者心血管风险评估及其与颈动脉内膜中层厚度的相关性
Nephrourol Mon. 2014 Nov 11;6(6):e22112. doi: 10.5812/numonthly.22112. eCollection 2014 Nov.
7
Serum magnesium, mortality, and cardiovascular disease in chronic kidney disease and end-stage renal disease patients: a systematic review and meta-analysis.血清镁、死亡率与慢性肾脏病和终末期肾病患者的心血管疾病:系统评价和荟萃分析。
J Nephrol. 2019 Oct;32(5):791-802. doi: 10.1007/s40620-019-00601-6. Epub 2019 Mar 19.
8
Association of serum magnesium with all-cause mortality in patients with and without chronic kidney disease in the Dallas Heart Study.血清镁与达拉斯心脏研究中伴有和不伴有慢性肾脏病患者全因死亡率的关系。
Nephrol Dial Transplant. 2018 Aug 1;33(8):1389-1396. doi: 10.1093/ndt/gfx275.
9
Elevated plasma levels of PAI-1 predict cardiovascular events and cardiovascular mortality in prevalent peritoneal dialysis patients.血浆 PAI-1 水平升高可预测现患腹膜透析患者的心血管事件和心血管死亡率。
Ren Fail. 2009;31(6):438-45. doi: 10.1080/08860220902963772.
10
Kidney Disease in Diabetes糖尿病肾病

引用本文的文献

1
Effect of serum magnesium level on carotid intima media thickness in hemodialysis patients.血清镁水平对血液透析患者颈动脉内膜中层厚度的影响。
BMC Nephrol. 2025 May 30;26(1):270. doi: 10.1186/s12882-025-04168-2.
2
Ionized and total magnesium levels in patients with chronic kidney disease: associated factors and outcomes.慢性肾脏病患者的离子化镁和总镁水平:相关因素及预后
Clin Kidney J. 2024 Feb 23;17(4):sfae046. doi: 10.1093/ckj/sfae046. eCollection 2024 Apr.
3
The association between serum magnesium and chronic kidney disease in Chinese adults: a cross-sectional study.

本文引用的文献

1
Magnesium in chronic kidney disease Stages 3 and 4 and in dialysis patients.慢性肾脏病 3 期和 4 期及透析患者的镁
Clin Kidney J. 2012 Feb;5(Suppl 1):i39-i51. doi: 10.1093/ndtplus/sfr166.
2
Relationship between serum magnesium levels and cardiovascular events in chronic kidney disease patients.血清镁水平与慢性肾脏病患者心血管事件的关系。
Am J Nephrol. 2012;36(3):228-37. doi: 10.1159/000341868. Epub 2012 Aug 30.
3
Relationship between magnesium and clinical biomarkers on inhibition of vascular calcification.镁与抑制血管钙化的临床生物标志物的关系。
血清镁与中国成年人慢性肾脏病的关系:一项横断面研究。
BMC Public Health. 2024 Jan 15;24(1):187. doi: 10.1186/s12889-023-17615-2.
4
A Higher Concentration of Dialysate Magnesium to Reduce the Frequency of Muscle Cramps: A Narrative Review.高浓度透析液镁以降低肌肉痉挛频率:一项叙述性综述。
Can J Kidney Health Dis. 2020 Oct 22;7:2054358120964078. doi: 10.1177/2054358120964078. eCollection 2020.
5
Serum magnesium, mortality, and cardiovascular disease in chronic kidney disease and end-stage renal disease patients: a systematic review and meta-analysis.血清镁、死亡率与慢性肾脏病和终末期肾病患者的心血管疾病:系统评价和荟萃分析。
J Nephrol. 2019 Oct;32(5):791-802. doi: 10.1007/s40620-019-00601-6. Epub 2019 Mar 19.
6
Magnesium: A Magic Bullet for Cardiovascular Disease in Chronic Kidney Disease?镁:慢性肾脏病心血管疾病的“万能子弹”?
Nutrients. 2019 Feb 22;11(2):455. doi: 10.3390/nu11020455.
7
Is low magnesium a clue to arteriovenous fistula complications in hemodialysis?低镁血症是血液透析中动静脉内瘘并发症的一个线索吗?
Int Urol Nephrol. 2016 May;48(5):773-9. doi: 10.1007/s11255-015-1207-6. Epub 2016 Jan 18.
Am J Nephrol. 2012;35(1):31-9. doi: 10.1159/000334742. Epub 2011 Dec 15.
4
Magnesium reduces calcification in bovine vascular smooth muscle cells in a dose-dependent manner.镁以剂量依赖的方式减少牛血管平滑肌细胞的钙化。
Nephrol Dial Transplant. 2012 Feb;27(2):514-21. doi: 10.1093/ndt/gfr321. Epub 2011 Jul 12.
5
Inflammation and elevation of C-reactive protein: does magnesium play a key role?炎症与C反应蛋白升高:镁是否起关键作用?
Magnes Res. 2009 Jun;22(2):57-9.
6
Magnesium supplementation helps to improve carotid intima media thickness in patients on hemodialysis.补充镁有助于改善血液透析患者的颈动脉内膜中层厚度。
Int Urol Nephrol. 2008;40(4):1075-82. doi: 10.1007/s11255-008-9410-3. Epub 2008 Jun 21.
7
Serum magnesium concentration is a significant predictor of mortality in maintenance hemodialysis patients.血清镁浓度是维持性血液透析患者死亡率的重要预测指标。
Magnes Res. 2007 Dec;20(4):237-44.
8
Phenylacetic acid and arterial vascular properties in patients with chronic kidney disease stage 5 on hemodialysis therapy.慢性肾脏病5期血液透析患者的苯乙酸与动脉血管特性
Nephron Clin Pract. 2007;107(1):c1-6. doi: 10.1159/000105137. Epub 2007 Jul 5.
9
Inverse correlation between serum magnesium and parathyroid hormone in peritoneal dialysis patients: a contributing factor to adynamic bone disease?腹膜透析患者血清镁与甲状旁腺激素的负相关:是动力缺失性骨病的一个促成因素?
Int Urol Nephrol. 2006;38(2):317-22. doi: 10.1007/s11255-006-0082-6.
10
Magnesium and the inflammatory response: potential physiopathological implications.镁与炎症反应:潜在的生理病理学意义
Arch Biochem Biophys. 2007 Feb 1;458(1):48-56. doi: 10.1016/j.abb.2006.03.031. Epub 2006 Apr 19.